Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123061852 | 12306185 | 2 | F | 1997 | 20160630 | 20160426 | 20160706 | PER | US-PFIZER INC-2016219578 | PFIZER | 41.00 | YR | F | Y | 86.00000 | KG | 20160706 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123061852 | 12306185 | 1 | PS | MEDROXYPROGESTERONE ACETATE. | MEDROXYPROGESTERONE ACETATE | 1 | Intramuscular | 1 DF, EVERY 84 DAYS | U | 20246 | 1 | DF | SUSPENSION FOR INJECTION | ||||||
| 123061852 | 12306185 | 2 | SS | MEDROXYPROGESTERONE ACETATE. | MEDROXYPROGESTERONE ACETATE | 1 | U | 20246 | SUSPENSION FOR INJECTION | ||||||||||
| 123061852 | 12306185 | 3 | C | ALLEGRA D 24 HOUR | 2 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123061852 | 12306185 | 1 | Hormone level abnormal |
| 123061852 | 12306185 | 2 | Menstrual discomfort |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123061852 | 12306185 | Chloasma | |
| 123061852 | 12306185 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123061852 | 12306185 | 1 | 1997 | 0 | ||
| 123061852 | 12306185 | 3 | 2006 | 0 |